489 results on '"Leleu, A"'
Search Results
2. A.R.R.O.W.2: once- vs twice-weekly carfilzomib, lenalidomide, and dexamethasone in relapsed/refractory multiple myeloma
3. Phylogenomic workflow for uncultivable microbial eukaryotes using single-cell RNA sequencing − A case study with planktonic ciliates (Ciliophora, Oligotrichea)
4. Impaired unsaturated fatty acid elongation alters mitochondrial function and accelerates metabolic dysfunction-associated steatohepatitis progression
5. Recent Developments in Convenience of Administration of the Anti-CD38 Antibody Isatuximab: Subcutaneous Delivery and Fast Intravenous Infusion in Patients With Multiple Myeloma
6. Daratumumab, carfilzomib, lenalidomide, and dexamethasone with tandem transplant for high-risk newly diagnosed myeloma
7. Role of astrocyte senescence regulated by the non– canonical autophagy in the neuroinflammation associated to cerebral malaria
8. How I treat multiple myeloma in geriatric patients
9. Voice categorization in the four-month-old human brain
10. A Meta-Analysis of the Efficacy of Pomalidomide-Based Regimens for the Treatment of Relapsed/Refractory Multiple Myeloma After Lenalidomide Exposure
11. Chromosome-level organization of the regulatory genome in the Drosophila nervous system
12. Hodgkin lymphoma and female fertility: a multicenter study in women treated with doxorubicin, bleomycin, vinblastine, and dacarbazine
13. Final analysis of carfilzomib, dexamethasone, and daratumumab vs carfilzomib and dexamethasone in the CANDOR study
14. Biallelic deletion of 1p32 defines ultra-high-risk myeloma, but monoallelic del(1p32) remains a strong prognostic factor
15. Rates of Influenza and Pneumococcal Vaccination and Correlation With Survival in Multiple Myeloma Patients
16. Intravenous and subcutaneous immunoglobulins-associated eczematous reactions occur with a broad range of immunoglobulin types: A French national multicenter study
17. Prediction of venous thromboembolism in patients with multiple myeloma treated with lenalidomide, bortezomib, dexamethasone, and transplantation: Lessons from the substudy of IFM/DFCI 2009 cohort
18. Smell what you hardly see: Odors assist visual categorization in the human brain
19. Bortezomib and high-dose melphalan conditioning regimen in frontline multiple myeloma: an IFM randomized phase 3 study
20. Implementing Lung Cancer Screening in Europe: Taking a Systems Approach
21. Primary plasma cell leukemias displaying t(11;14) have specific genomic, transcriptional, and clinical features
22. Results of Second Round Lung Cancer Screening by Low-Dose CT scan - French Cohort Study (DEP-KP80)
23. Epidemiological landscape of young patients with multiple myeloma diagnosed before 40 years of age: the French experience
24. Up-front carfilzomib, lenalidomide, and dexamethasone with transplant for patients with multiple myeloma: the IFM KRd final results
25. Denosumab compared with zoledronic acid on PFS in multiple myeloma: exploratory results of an international phase 3 study
26. Categorization of objects and faces in the infant brain and its sensitivity to maternal odor: further evidence for the role of intersensory congruency in perceptual development
27. Lung Cancer Screening by Low-Dose CT Scan: Baseline Results of a French Prospective Study
28. Expertise for conspecific face individuation in the human brain
29. Dietary zinc source impacts intestinal morphology and oxidative stress in young broilers
30. Predictors of Lenalidomide Refractory Relapse Timing With Newly Diagnosed Multiple Myeloma: A FIRST Trial Subanalysis
31. Residential exposure to ultra high frequency electromagnetic fields emitted by Global System for Mobile (GSM) antennas and amyotrophic lateral sclerosis incidence: A geo-epidemiological population-based study
32. Clinicopathological spectrum of renal parenchymal involvement in B-cell lymphoproliferative disorders
33. Exploratory case study of monozygotic twins with 22q11.2DS provides further clues to circumscribe neurocognitive markers of psychotic symptoms
34. Role of Proteasome Inhibitors in Relapsed and/or Refractory Multiple Myeloma
35. RAS/RAF landscape in monoclonal plasma cell conditions
36. Pomalidomide, cyclophosphamide, and dexamethasone for relapsed multiple myeloma
37. Minimal residual disease negativity using deep sequencing is a major prognostic factor in multiple myeloma
38. Myeloma MRD by deep sequencing from circulating tumor DNA does not correlate with results obtained in the bone marrow
39. Tuning functions for automatic detection of brief changes of facial expression in the human brain
40. Working Toward a Genomic Prognostic Classification of Waldenström Macroglobulinemia: C-X-C Chemokine Receptor Type 4 Mutation and Beyond
41. Outcome of a Salvage Third Autologous Stem Cell Transplantation in Multiple Myeloma
42. Final analysis of survival outcomes in the phase 3 FIRST trial of up-front treatment for multiple myeloma
43. Prognostic role of circulating exosomal miRNAs in multiple myeloma
44. Serum free light chains, not urine specimens, should be used to evaluate response in light-chain multiple myeloma
45. VANTAGE 095: An International, Multicenter, Open-Label Study of Vorinostat (MK-0683) in Combination With Bortezomib in Patients With Relapsed and Refractory Multiple Myeloma
46. Oestrogen reporter transgenic medaka for non-invasive evaluation of aromatase activity
47. TCL1 expression patterns in Waldenström macroglobulinemia
48. Understanding the role of hyperdiploidy in myeloma prognosis: which trisomies really matter?
49. American Society of Blood and Marrow Transplantation, European Society of Blood and Marrow Transplantation, Blood and Marrow Transplant Clinical Trials Network, and International Myeloma Working Group Consensus Conference on Salvage Hematopoietic Cell Transplantation in Patients with Relapsed Multiple Myeloma
50. Interaction between fat type and lysolecithin supplementation in broiler feeds
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.